Y-Intercept (HK)’s Definitive Healthcare DH Stock Holding History

Y-Intercept (HK)’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,187	Closed	-$123K	–	1245
2022 Q4	$123K	Buy	+11,187	New	+$144K	0.02%	885

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Y-Intercept (HK)'s DH Position: Q1 2023 in Review

Y-Intercept (HK) sold out of Definitive Healthcare (DH) in Q1 2023, closing a stake of 11,187 shares — an estimated $123K sold.

Y-Intercept (HK) first reported a position in DH in Q4 2022 and held it in 1 quarter. The position peaked at $123K in Q4 2022. 144 funds tracked by Wall St. Rank hold DH as of Q1 2023.

Y-Intercept (HK) reported no remaining Definitive Healthcare position as of Q1 2023 after selling out during the quarter.
Y-Intercept (HK) sold 11,187 Definitive Healthcare shares in Q1 2023, an estimated $123K.
Y-Intercept (HK) first reported a position in Definitive Healthcare in Q4 2022 and held it in 1 quarter.
Y-Intercept (HK)'s Definitive Healthcare position peaked at $123K in Q4 2022.
144 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2023.

Based on Y-Intercept (HK)'s 13F filing for Q1 2023, filed 9 May 2023.